...
首页> 外文期刊>European review for medical and pharmacological sciences. >Highly standardized cranberry extract supplementation (Anthocran?) as prophylaxis in young healthy subjects with recurrent urinary tract infections
【24h】

Highly standardized cranberry extract supplementation (Anthocran?) as prophylaxis in young healthy subjects with recurrent urinary tract infections

机译:高度标准化的蔓越莓提取物补充剂(Anthocran?)预防尿路感染的年轻健康受试者

获取原文
           

摘要

OBJECTIVE: Several studies have investigated the role of cranberry extract in the prevention of recurrent urinary tract infections (UTIs), on different selected subpopulations at increased risk of UTI. In this registry, we tested the prophylactic effects of an oral supplementation containing a highly standardized cranberry extract (Anthocran?) in young subjects with a previous history of recurrent UTIs, over a 2-months follow-up. PATIENTS AND METHODS: 36 otherwise healthy subjects in juvenile age (between 12 and 18 years of age) suffering by recurrent UTIs were enrolled. Participants received either a standard management (SM) (control group, n=17) or SM associated with an oral daily supplementation (supplementation group, n=19). Oral supplementation consisted in one capsule containing 120 mg of cranberry extract (Anthocran?), standardized to 36 mg proanthocyanidins, for 60 days. The effectiveness in the prevention of UTIs was determined by: the number of UTIs evaluated two months before the inclusion in the registry and during the supplementation period; the number of symptom-free subjects during the registry period. Safety considerations and measurement of adherence to treatment were also performed. RESULTS: The two groups were comparable for age, gender distribution, the days of follow-up and also for the number of UTIs before inclusion. The mean number of UTIs observed during the registry in the supplemented group (0.31±0.2) was significantly lower compared to the control group (2.3±1.3) and to the mean number of UTIs assessed before inclusion (1.74±1.1) (p-value = 0.0001 for both). Moreover, 63.1% of supplemented subjects was symptom-free during the registry period, whereas 23.5% subjects were asymptomatic in the control group (p-value <0.05). CONCLUSIONS: This registry supplement study provides compelling evidence on the efficacy of an oral supplementation, based on a highly standardized cranberry extract (Anthocran?), as prophylaxis in young healthy subjects suffering by recurrent UTIs.
机译:目的:有几项研究调查了蔓越莓提取物在预防尿路感染风险增加的不同选定亚人群中预防反复尿路感染(UTI)的作用。在该注册表中,我们在2个月的随访中测试了含有高度标准化的蔓越莓提取物(Anthocran?)的口服补充剂对先前有UTI复发史的年轻受试者的预防作用。患者和方法:招募了36名患有UTI复发的健康年龄在12岁至18岁之间的健康受试者。参与者接受了标准管理(SM)(对照组,n = 17)或与口服每日补充剂相关的SM(补充组,n = 19)。口服补充剂在一个胶囊中放置60天,该胶囊含有120 mg蔓越莓提取物(Anthocran?),标准化为36 mg原花青素。预防UTI的有效性取决于:在纳入注册表之前两个月以及在补充期间评估的UTI数量;注册期间无症状受试者的数量。还进行了安全考虑和对治疗依从性的测量。结果:两组在年龄,性别分布,随访天数以及入组前UTIs数量上均具有可比性。补充组在注册表中观察到的UTI的平均数(0.31±0.2)显着低于对照组(2.3±1.3)和纳入前评估的UTI的平均数(1.74±1.1)(p值两者均为0.0001)。此外,在注册期间,63.1%的补充受试者无症状,而对照组的23.5%受试者无症状(p值<0.05)。结论:该注册表补充研究提供了基于高度标准化的蔓越莓提取物(Anthocran?)口服补充剂作为预防复发性UTI的年轻健康受试者的功效的令人信服的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号